| |
 |
| September
06, 2001 |
Keryx
Reports Second Quarter 2001 Financial Results |
| September
06, 2001 |
Keryx
Biopharm Q2 net loss 3.45 mln usd vs 3.23 mln |
| September
06, 2001 |
Keryx
Biopharmaceuticals' KRX-101 granted fast-track status by US FDA |
| May
15, 2001 |
Keryx
Reports First Quarter 2001 Financial Results |
| March
29, 2001 |
Keryx
Reports Fourth Quarter and Year End 2000 Financial Results |
| February
12, 2001 |
Keryx
Awarded Critical U.S. Patent For Gene-Based Drug Discovery Involving
Kinase Targeted Compounds |
| February
6, 2001 |
Keryx
Biopharmaceuticals Appoints J. Wilson Totten, M.D. and Malcom I. Hoenlein
to Board of Directors |
| January
29, 2001 |
Keryx
Biopharmaceuticals Secures U.S. Patent For Use of KRX-101 Against
Diabetic Retinopathy |
| November
29, 2000 |
Keryx
Biopharmaceuticals Appoints Ron Bentsur Global Head of Investor Relations |
| November
14, 2000 |
Keryx
Reports Third Quarter 2000 Financial Results |
| October
17, 2000 |
Keryx
Plans Move to Main London Market |
| September
27, 2000 |
Keryx
Biopharmaceuticals Provides Update on KRX-101 Clinical Development
Program |
| September
11, 2000 |
KERYX
BIOPHARMACEUTICALS INC files Form 10-Q, Quarterly Report of Financial
Condition |
| September
11, 2000 |
Keryx
Reports Second Quarter 2000 Financial Results |
| August
31, 2000 |
Keryx
Biopharmaceuticals, Inc. Announces Exercise of Over-Allotment Option |
| August
2, 2000 |
KERYX
BIOPHARMACEUTICALS, INC. ANNOUNCES START OF DEALINGS IN FIRST-EVER
JOINT AIM / NASDAQ IPO |
| July
28, 2000 |
Keryx
Biopharmaceuticals, Inc. Announces Initial Public Offering |
| January
25, 2000 |
Keryx
Biopharmaceuticals Raises $8.8 Million in Private Placement |
 |
| August
2, 2000 |
PA
Consulting Group Supports First, Simultaneous Nasdaq/Aim Listing - for
an Israeli Biotech Start-Up Company, Keryx Biopharmaceuticals, Inc |
PA
Consulting Group |
| July
19, 2000 |
Keryx
Plans $250m Dual Listing |
Financial
Times |
| June,
2000 |
Keryx
Readies for IPO, New Drug Trials |
THGC
Giza Investment Letter |
| January
26, 2000 |
Keyrx
Sees IPO at $200m Valuation |
Jerusalem
Post |
| January
25, 2000 |
Keryx
Biopharmaceuticals Raises $8.8 Million in Private Placement |
Globes |
| January
25, 2000 |
Keryx,
With Drugs for Cancer, Hair Loss and Obesity, Plans IPO |
Bloomberg
News Wires |
| January
25, 2000 |
Drug
Developer KERYX Aims for Public Issue in 2000 |
Reuters |
| January
2, 2000 |
Keryx
Raises $8.8M Privately To Fund KinAce Technology |
BioWorld
International |
|
|
